Peng Huang, University of Texas, USAProfessor Huang’s laboratory investigates the fundamental changes in energy metabolism and redox regulation in cancer. They aim to develop novel strategies to selectively kill the malignant cells based on their metabolic alterations and survival pathways.
Stefan Kempa, Berlin Institute for Medical Systems Biology, GermanyDr. Kempa’s laboratory investigates turnover rates of proteins and metabolites using stable isotope incorporation as well as temporal quantitative changes by analysing time series after perturbation or different developmental stages. Also data analysis and integration is in the focus of their interest.
Ursula Klingmüller, German Cancer Research Center, GermanyProfessor Klingmüller’s laboratory studies molecular mechanisms that regulate cellular decisions and their impact on behavior at the tissue and organ level. They aim to establish integrated models of signaling pathways, to link them to gene regulation as well as cell-cell communication and to include cell cycle progression and cell survival
Anna Krook, Karolinska Institutet, SwedenProfessor Krook’s laboratory aims to discover and validate targets important in metabolic disease, for example glucose homeostasis and Type 2 diabetes mellitus.
Etienne Meylan, EPFLProfessor Meylan’s laboratory uses human and mouse models to study NF-kB signaling and glucose metabolism in non-small cell lung cancer.
Dr. Nicola Zamboni, ETH Zürich, Institute of Molecular Systems Biology (ETHZ-IMSB), Switzerland
Dr. Zamboni´s group research interests focus in cellular metabolism, how it drives cellular decisions and differentiation, and how it sustains pathological states in disease.
To address these questions, Dr.Zamboni´s group have develop and apply advanced techniques to monitor the activity of metabolic networks. Their approaches build largely on mass spectrometry (i.e. high-throughput and quantitative metabolomics, tracer studies, dynamic experiments) and computational analysis for data processing, mining, and integration. In particular, Dr.Zamboni group strive to develop generally applicable, data-driven methods that can cope with the complexity of mammalian cells or dynamic systems.
Dr.Zamboni´s group developed toolbox which are applied broadly on very different systems (microbes, worms, cell lines, mice, primary human cells and tissues, etc.).
Dr.Roland Nilson, Center for Molecular Medicine, Karolinska University Hospital
Dr.Roland Nilson´s group specializes in detailed analyses of cellular metabolism using modern measurement techniques and mathematical models. Their work aims for a deeper and more quantitative understanding of how various cell types in the human body process nutrients to harvest energy and synthesize macromolecules. In particular, they are interested in the metabolic derangements that occur in cancer cells, but also in specialized modes metabolism unique to other cell types.
Dr.Roland Nilson was a key co-author in the development of a technique known as CORE (COnsumption and RElease) profiling, which yielded the first large-scale atlas of cancer metabolism and points to a key role for the smallest amino acid, glycine, in cancer cell proliferation.
Dr. Roland Nilson´s lab is at the Karolinska Institutet in Stockholm, Sweden, and have close collaboration with the University of California, San Diego, as well as Harvard University and the Broad Institute (Boston).
Markus Perola, National Institute for Health and Welfare (THL) and University of Helsinki, Finland
Professor Perola´s group are developers and/or collaborators of several national population cohorts (e.g. FINRISK and Health 2000) and international genetic consurtiums studies (e.g. BioSHare, BBMRI ENGAGE, GenomEUtwin, GEHA, MORGAM and GIANT). Professor Perola group research interests involve the genetic factors associated to obesity development and its complication.
Ann Van Schepdael, Pharmaceutical Analysis, KU Leuven, Belgium
Professor Van Schepdael´s group research interests cover the chemical modification of aminoglycoside antibiotics aimed at obtaining active compounds with decrease toxicity. Currently her group is also interested in protease inhibitors and applying electrophoretically mediated microanalysis.
Klaudia Walter, Wellcome Trust Sanger Institute, UK
info: coming soon....
Stefan Kempa, Berlin Institute for Medical Systems Biology, GermanyDr. Kempa’s laboratory investigates turnover rates of proteins and metabolites using stable isotope incorporation as well as temporal quantitative changes by analysing time series after perturbation or different developmental stages. Also data analysis and integration is in the focus of their interest.
Ursula Klingmüller, German Cancer Research Center, GermanyProfessor Klingmüller’s laboratory studies molecular mechanisms that regulate cellular decisions and their impact on behavior at the tissue and organ level. They aim to establish integrated models of signaling pathways, to link them to gene regulation as well as cell-cell communication and to include cell cycle progression and cell survival
Anna Krook, Karolinska Institutet, SwedenProfessor Krook’s laboratory aims to discover and validate targets important in metabolic disease, for example glucose homeostasis and Type 2 diabetes mellitus.
Etienne Meylan, EPFLProfessor Meylan’s laboratory uses human and mouse models to study NF-kB signaling and glucose metabolism in non-small cell lung cancer.
Dr. Nicola Zamboni, ETH Zürich, Institute of Molecular Systems Biology (ETHZ-IMSB), Switzerland
Dr. Zamboni´s group research interests focus in cellular metabolism, how it drives cellular decisions and differentiation, and how it sustains pathological states in disease.
To address these questions, Dr.Zamboni´s group have develop and apply advanced techniques to monitor the activity of metabolic networks. Their approaches build largely on mass spectrometry (i.e. high-throughput and quantitative metabolomics, tracer studies, dynamic experiments) and computational analysis for data processing, mining, and integration. In particular, Dr.Zamboni group strive to develop generally applicable, data-driven methods that can cope with the complexity of mammalian cells or dynamic systems.
Dr.Zamboni´s group developed toolbox which are applied broadly on very different systems (microbes, worms, cell lines, mice, primary human cells and tissues, etc.).
Dr.Roland Nilson, Center for Molecular Medicine, Karolinska University Hospital
Dr.Roland Nilson´s group specializes in detailed analyses of cellular metabolism using modern measurement techniques and mathematical models. Their work aims for a deeper and more quantitative understanding of how various cell types in the human body process nutrients to harvest energy and synthesize macromolecules. In particular, they are interested in the metabolic derangements that occur in cancer cells, but also in specialized modes metabolism unique to other cell types.
Dr.Roland Nilson was a key co-author in the development of a technique known as CORE (COnsumption and RElease) profiling, which yielded the first large-scale atlas of cancer metabolism and points to a key role for the smallest amino acid, glycine, in cancer cell proliferation.
Dr. Roland Nilson´s lab is at the Karolinska Institutet in Stockholm, Sweden, and have close collaboration with the University of California, San Diego, as well as Harvard University and the Broad Institute (Boston).
Markus Perola, National Institute for Health and Welfare (THL) and University of Helsinki, Finland
Professor Perola´s group are developers and/or collaborators of several national population cohorts (e.g. FINRISK and Health 2000) and international genetic consurtiums studies (e.g. BioSHare, BBMRI ENGAGE, GenomEUtwin, GEHA, MORGAM and GIANT). Professor Perola group research interests involve the genetic factors associated to obesity development and its complication.
Ann Van Schepdael, Pharmaceutical Analysis, KU Leuven, Belgium
Professor Van Schepdael´s group research interests cover the chemical modification of aminoglycoside antibiotics aimed at obtaining active compounds with decrease toxicity. Currently her group is also interested in protease inhibitors and applying electrophoretically mediated microanalysis.
Klaudia Walter, Wellcome Trust Sanger Institute, UK
info: coming soon....